5 Results for "

2,5-Furandicarboxylic acid

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "2,5-Furandicarboxylic acid" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-W002105
CAS No.: 3238-40-2
2,5-Furandicarboxylic acid is an endogenous metabolite that can be detected in human urine. 2,5-Furandicarboxylic acid serves as an environmentally friendly substitute for terephthalic acid in the production of polyesters. 2,5-Furandicarboxylic acid can be used as the raw material for various chemical intermediates to synthesize polymers, polyurethanes, thermosetting resins, and plasticizers .
loading...
    loading...
Cat. No.: HY-W748193
CAS No.: 2816171-80-7
2,5-Furandicarboxylic acid- 13C6 is the 13C-labeled 2,5-Furandicarboxylic acid.
loading...
    loading...
Cat. No.: HY-W002105R
CAS No.: 3238-40-2
2,5-Furandicarboxylic acid (Standard) is the analytical standard of 2,5-Furandicarboxylic acid (HY-W002105). This product is intended for research and analytical applications. 2,5-Furandicarboxylic acid is an endogenous metabolite that can be detected in human urine. 2,5-Furandicarboxylic acid serves as an environmentally friendly substitute for terephthalic acid in the production of polyesters. 2,5-Furandicarboxylic acid can be used as the raw material for various chemical intermediates to synthesize polymers, polyurethanes, thermosetting resins, and plasticizers .
loading...
    loading...
Cat. No.: HY-P10563
CAS No.: 2580150-96-3
Synonyms: BHV-1100
Target:  

CD38 IFNAR

Research Areas:  

Cancer

Noraramtide (BHV-1100) is an antibody-recruiting molecule. Noraramtide binds to CD38 and recruits natural killer (NK) cells to mediate antibody-dependent cellular cytotoxicity. Noraramtide enhances the capacity of autologous cytokine-induced memory-like (CIML) NK cells to produce IFNγ and CD107a, thereby improving their cytotoxicity against multiple myeloma cells. Noraramtide can be used in the research of multiple myeloma .
loading...
    loading...
Cat. No.: HY-P11243
Target:  

Ephrin Receptor

Research Areas:  

Neurological Disease

EphA4 agonist compound 23 is a novel EphA4 agonist peptide mimic. EphA4 agonist compound 23 exhibits high affinity, high selectivity, and significant receptor activation ability. EphA4 agonist compound 23 is commonly used in the study of neurodegenerative diseases .
loading...
    loading...